Pressroom: Media Coverage

Showing 181 - 200 of 656 news items


Same Gene Mutations Tied to 12 Cancers

Cancer geneticist Michael Berger commented on new research that identified genetic mutations that are common among 12 types of cancer.

October 16, 2013
Breaking Through Cancer's Shield

Medical oncologist Renier Brentjens and cell researcher Michel Sadelain commented on recent advances that use the body’s own immune system to fight cancer.

October 15, 2013
The Soaring Cost of a Simple Breath

Epidemiologist Peter Bach commented on the high price of commonly used medications that contribute heavily to healthcare costs.

October 13, 2013
Screw You Cancer

A Memorial Sloan Kettering patient shared her decision to have a preventative double mastectomy after learning she’s BRCA1-positive in this documentary series. Her breast surgeon Mary Gemignani, plastic surgeon Andrea Pusic, and genetic counselor Mark Robson were all featured in the film.

October 9, 2013
Weighing Surgeries in Light of a Breast Cancer Gene

Gynecologic oncologist Nadeem Abu-Rustum commented on risk-reducing surgery for women with BRCA gene mutations.

October 7, 2013
Breast Cancer Special: Answers, Updates, and Progress

Medical oncologist Andrew Seidman discussed Memorial Sloan Kettering’s collaboration with IBM Watson and the benefits it will bring to treating patients, and medical oncologist Victoria Blinder discussed psycho-social issues that can come into play when a person is going through cancer treatment.

October 5, 2013
Breast Cancer Special: Answers, Updates, and Progress

Medical oncologist Heather McArthur and interventional radiologist Stephen Solomon were interviewed about a clinical trial being offered at Memorial Sloan Kettering for breast cancer patients.

October 5, 2013
10 Ways to Stop Breast Cancer

Surgical oncologist Mary Gemignani offered tips to help women overcome their breast cancer fears.

October 1, 2013
The Intriguing Health Benefits of Qigong

Integrative medicine specialist Yang Yang spoke about the use of qigong for cancer patients.

September 30, 2013
Cancer Cartography

Computational biologist Chris Sander developed an algorithm to examine more than 3,000 tumors, and was able to group them into two distinct categories based on their genetic makeup.

September 27, 2013
Science and the Arts

Visible Ink Founder Judith Kelman was interviewed about the program that offers patients at Memorial Sloan Kettering the opportunity to work one-on-one with an experienced mentor on a writing project of their choice.

September 24, 2013
Going Pink: 7 Things You Need to Know Now About Breast Cancer

Medical oncologist Clifford Hudis weighed in on what Americans should know now about breast cancer.

September 23, 2013
IBM's Massive Bet on Watson

Medical oncologist Mark Kris explained how Memorial Sloan Kettering’s partnership with IBM and its Watson technology can help doctors make treatment decisions.

September 19, 2013
Sloan Kettering to Form Ties with Smaller Cancer Centers

Memorial Sloan Kettering launched a transformative initiative to improve the quality of cancer care and the lives of cancer patients. Hartford HealthCare was selected as a pioneering member of the newly formed Memorial Sloan Kettering Cancer Alliance.

September 17, 2013
Reality Check on Cancer: Fast Progress but Too Many Preventable Deaths

Physician-scientist Charles Sawyers commented on the latest status report from the American Association for Cancer Research that shows that most cancer deaths are avoidable.

September 17, 2013
Reishi Mushrooms as Remedy?

Herbalist K. Simon Yeung spoke about the cancer-fighting properties of reishi mushrooms.

September 17, 2013
Looking for Lessons in Cancer's 'Miracle' Responders

Cancer researcher David Solit was profiled about his research to uncover why certain patients respond well to drugs that did not help others.

September 15, 2013
New Hope for Breast Cancer Patients

Breast surgeon Mary Gemignani discussed a drug that could be used to shrink tumors in breast cancer patients prior to surgery.

September 14, 2013
FDA Panel Backs Pre-Surgery Drug for Breast Cancer

Memorial Sloan Kettering Physician-in-Chief José Baselga commented on the recommendation from a federal advisory panel to approve the first drug that would be used in early-stage breast cancer patients, prior to surgery.

September 13, 2013